Biotech

All Articles

Cassava pays for $40M over supposedly deceiving Alzheimer's upgrade

.Cassava Sciences has actually consented to spend $40 million to solve an inspection right into clai...

Merck bags options on Evaxion's AI-designed vaccine candidates

.Merck &amp Co. has gotten alternatives on 2 Evaxion Biotech vaccination candidates, paying $3.2 mil...

Enanta's RSV antiviral crushes virus-like load in difficulty research

.Enanta Pharmaceuticals has connected its respiratory syncytial infection (RSV) antiviral to substan...

Biogen containers SAGE-324 partnership after crucial shake neglect

.Biogen has conducted the last rites to its partnership with Sage Therapeutics on SAGE-324, ditching...

AbbVie Parkinson's drug from $8.7 B Cerevel purchase scores

.On the very same day that some Parkinson's illness drugs are being brought into question, AbbVie ha...

Arch shuts $3B-plus fund to promote biopharma upstarts

.On the heels of a $3 billion fund from Bain Funds Lifestyle Sciences, Arch Project Partners is actu...

Orion to use Aitia's 'electronic identical twins' to discover new cancer cells medications

.Finnish biotech Orion has actually spied prospective in Aitia's "electronic twin" specialist to bui...

Windtree's surprise med raises high blood pressure in most up-to-date phase 2 win

.While Windtree Rehabs has had a hard time to grow the financial origins required to survive, a phas...

2 cancer biotechs merge, making international footprint

.OncoC4 is taking AcroImmune-- and its own in-house scientific production capabilities-- under its o...

Amgen records very first stage 3 win for $400M chronic eczema medicine

.Amgen has actually discussed (PDF) the 1st period 3 records on its $400 million chronic eczema drug...